Determination of antibodies to Toxoplasma gondii and CMV in renal transplant recipients

By Iqbal J.   Nampoory M.R.N.   Johnv K.V.   Khalid N.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2703-2705

Elsevier

Access to resources Recommend Favorite

Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients

By Post A.B.   Mulligan D.C.   Bush W.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2102-2103

Elsevier

Access to resources Recommend Favorite

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant ''CMV at Risk'' Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

By Ahsan N.   Holman M.J.   Sonderbye L.   Langhoff E.   Yang H.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1383-1385

Elsevier

Access to resources Recommend Favorite

Differentiation of CMV-specific CD8 POS T lymphocytes in primary CMV infection after renal transplantation

By ten Berge I.J.M.   Gamadia L.E.   Remmerswaal E.B.M.   Surachno S.   Weel J.F.L.   Toebes M.   Schumacher T.N.M.   van Lier R.A.W.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3630-3630

Elsevier

Access to resources Recommend Favorite

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite